Page 44 - 80_01
P. 44
SREBP--1c,
ChREBP
y
LXR…
94. Chen,
G.,
Liang,
G.,
Ou,
J.
y
col.
2004.
Central
role
for
liver
X
receptor
in
insulin--mediated
activation
of
Srebp--1c
transcription
and
stimulation
of
fatty
acid
synthesis
in
liver.
Proc
Natl
Acad
Sci
U
S
A
101,
11245--11250.
95. Ye,
J.,
DeBose--Boyd,
R.A.,
2011.
Regulation
of
cholesterol
and
fatty
acid
synthesis.
Cold
Spring
Harb
Perspect
Biol
3.
pii:
a0047
96. Bobard,
A.,
Hainault,
I.,
Ferré,
P.
y
col.
2005.
Differential
regulation
of
sterol
regulatory
element--binding
protein
1c
transcriptional
activity
by
insulin
and
liver
X
receptor
during
liver
development.
J
Biol
Chem
280,
199--206.
97. Horton,
J.D.,
Bashmakov,
Y.,
Shimomura,
I.,
Shimano,
H.,
1998.
Regulation
of
sterol
regulatory
element
binding
proteins
in
livers
of
fasted
and
refed
mice.
Proc
Natl
Acad
Sci
U
S
A
95,
5987--599217.
98. Hasty,
A.H.,
Shimano,
H.,
Yahagi,
N.,
Amemiya--Kudo,
M.
y
col.
2000.
Sterol
regulatory
element--binding
protein--1
is
regulated
by
glucose
at
the
transcriptional
level.
J
Biol
Chem
275,
31069--31077.
99. Dentin,
R.,
Pégorier,
J.P.,
Benhamed,
F.
y
col.
2004.
Hepatic
glucokinase
is
required
for
the
synergistic
action
of
ChREBP
and
SREBP--1c
on
glycolytic
and
lipogenic
gene
expression.
J
Biol
Chem
279,
20314--20326.
100. Liang,
G.,
Yang,
J.,
Horton,
J.D.
y
col.
2002.
Diminished
hepatic
response
to
fasting/refeeding
and
liver
X
receptor
agonists
in
mice
with
selective
deficiency
of
sterol
regulatory
element--binding
protein--1c.
J
Biol
Chem
277,
9520--9528.
101. Nagai,
Y.,
Yonemitsu,
S.,
Erion,
D.M.
y
col.
2009.
The
role
of
peroxisome
proliferator--activated
receptor
gamma
coactivator--1
beta
in
the
pathogenesis
of
fructose--
induced
insulin
resistance.
Cell
Metab
9,
252--264.
102. Lee,
J.N.,
Zhang,
X.,
Feramisco,
J.D.
y
col.
2008.
Unsaturated
fatty
acids
inhibit
proteasomal
degradation
of
Insig--1
at
a
postubiquitination
step.
J
Biol
Chem
283,
33772--
33783.
103. Kammoun,
H.L.,
Chabanon,
H.,
Hainault,
I.
y
col.
2009.
GRP78
expression
inhibits
insulin
and
ER
stress--induced
SREBP--1c
activation
and
reduces
hepatic
steatosis
in
mice.
J
Clin
Invest
119,
1201--1215.
104. Inoue,
J.,
Ito,
Y.,
Shimada,
S.
y
col.
2011.
Glutamine
stimulates
the
gene
expression
and
processing
of
sterol
regulatory
element
binding
proteins,
thereby
increasing
the
expression
of
their
target
genes.
FEBS
J
278,
2739--2750.
105. Xia,
M.,
Liu,
Y.,
Guo,
H.
y
col.
2013.
Retinol
binding
protein
4
stimulates
hepatic
sterol
regulatory
element--binding
protein
1
and
increases
lipogenesis
through
the
peroxisome
proliferator--activated
receptor--?
coactivator
1ß--dependent
pathway.
Hepatology
58,
564--575.
106. Zhang,
Y.,
Lei,
T.,
Huang,
J.F.
y
col.
2011.
The
link
between
fibroblast
growth
factor
21
and
sterol
regulatory
element
binding
protein
1c
during
lipogenesis
in
hepatocytes.
Mol
Cell
Endocrinol
342,
41--47.
107. Ruderman,
N.B.,
Xu,
X.J.,
Nelson,
L.
y
col.
2010.
AMPK
and
SIRT1:
a
long--standing
partnership?
Am
J
Physiol
Endocrinol
Metab
298,
E751--760.
108. Bécard,
D.,
Hainault,
I.,
Azzout--Marniche,
D.
y
col.
2001.
Adenovirus--mediated
overexpression
of
sterol
regulatory
element
binding
protein--1c
mimics
insulin
effects
on
hepatic
gene
expression
and
glucose
homeostasis
in
diabetic
mice.
Diabetes
50,
2425--
2430.
109. Lemoine,
M.,
Barbu,
V.,
Girard,
P.M.
y
col.
2006.
Altered
hepatic
expression
of
SREBP--1
and
PPARgamma
is
associated
with
liver
injury
in
insulin--resistant
lipodystrophic
HIV--infected
patients.
AIDS
20,
387--395.
110. Eberlé,
D.,
Clément,
K.,
Meyre,
D.
y
col.
2004.
SREBF--1
gene
polymorphisms
are
associated
with
obesity
and
type
2
diabetes
in
French
obese
and
diabetic
cohorts.
Diabetes
53,
2153--2157.
111. Biddinger,
S.B.,
Almind,
K.,
Miyazaki,
M.
y
col.
2005.
Effects
of
diet
and
genetic
background
on
sterol
regulatory
element--binding
protein--1c,
stearoyl--CoA
desaturase
1,
and
the
development
of
the
metabolic
syndrome.
Diabetes
54,
1314--1323.
112. Teran--Garcia,
M.,
Adamson,
A.W.,
Yu,
G.
y
col.
2007.
Polyunsaturated
fatty
acid
suppression
of
fatty
acid
synthase
(FASN):
evidence
for
dietary
modulation
of
NF--Y
binding
to
the
Fasn
promoter
by
SREBP--1c.
Biochem
J
402,
591--600.
113. Leavens,
K.F.,
Easton,
R.M.,
Shulman,
G.I.
y
col.
2009.
Akt2
is
required
for
hepatic
lipid
accumulation
in
models
of
insulin
resistance.
Cell
Metab
10,
405--418.
43
